通宇通訊(002792.SZ):公司在6G領域已有半成品
格隆匯5月26日丨通宇通訊(002792.SZ)於2023年5月25日15:00-17:00接受機構調研、現場參觀,公司表示,目前海外部分國家調整網絡設備採購政策,公司海外業務受到一定影響,去年公司引入了同行業大公司國際化銷售人才佈局到海外各辦事處,在重點區域增設辦事處,實現本地化經營,同時推進海外倉儲、海外建廠佈局,海外市場在下半年、未來幾年內有機會實現較大增長。
公司打造新一代高性能天線,產品結構和工藝都上了一個新的台階,新產品重點拓展國外高端市場。今年公司設立成都毫米波公司,重點發展面向特殊領域應用的衞星通信終端、雷達、毫米波及數據鏈終端產品,公司在6G領域已有半成品,行業地位穩固。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.